The genetic background significantly impacts the severity of kidney cystic disease in the Pkd1RC/RC mouse model of autosomal dominant polycystic kidney disease
- 1 June 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1392-1407
- https://doi.org/10.1016/j.kint.2021.01.028
Abstract
No abstract availableFunding Information
- NIDDK
This publication has 90 references indexed in Scilit:
- Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney DiseaseThe New England Journal of Medicine, 2012
- Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severityJCI Insight, 2012
- Mouse genomic variation and its effect on phenotypes and gene regulationNature, 2011
- Sex differences in vasopressin V2 receptor expression and vasopressin-induced antidiuresisAmerican Journal of Physiology-Renal Physiology, 2011
- Patterning a Complex Organ: Branching Morphogenesis and Nephron Segmentation in Kidney DevelopmentDevelopmental Cell, 2010
- Renal injury is a third hit promoting rapid development of adult polycystic kidney diseaseHuman Molecular Genetics, 2009
- Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney diseaseKidney International, 2009
- Functional coding variation in recombinant inbred mouse lines reveals multiple serotonin transporter-associated phenotypesProceedings of the National Academy of Sciences of the United States of America, 2009
- Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structureProceedings of the National Academy of Sciences of the United States of America, 2007
- A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1Nature Medicine, 2007